This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ten-Patient Case-Control Study

Jan Karel M. Eeftinck Schattenkerk, MD; Sven A. Danner, MD, PhD; Joep M. A. Lange, MD; Deborah A. Paul, PhD; Chris J. van Boxtel, MD, PhD; Frank Miedema, PhD; Peter Th. A. Schellekens, MD, PhD; Jaap Goudsmit, MD, PhD

Arch Intern Med. 1988;148(1):209-211.

Abstract
• Ten homosexual men with the acquired immunodeficiency syndrome were included in a serologic follow-up study (duration, 40 weeks) of human immunodeficiency virus (HIV) antigenemia. Five of these men were treated with the reverse transcriptase inhibitor, suramin, for a period of 19 to 37 weeks. In contrast with reported changes in HIV antigen levels after treatment with zidovudine, HIV antigenemia persisted in the suramin-treated group, as well as in the untreated group. No clinical or immunologic improvement was seen in either group within the observation period. These data add evidence to the notion that monitoring HIV antigen levels helps to assess the efficacy of antiviral therapy.

(Arch Intern Med 1988;148:209-211)

Author Affiliations
From the Departments of Internal Medicine (Drs Eeftinck Schattenkerk, Danner, Lange, and Schellekens), Virology (Drs Lange and Goudsmit), and Clinical Pharmacology (Dr Boxtel), and Laboratory of Clinical and Experimental Immunology (Dr Schellekens), Academic Medical Center, University of Amsterdam; Diagnostic Division, Abbott Laboratories, North Chicago, Ill (Dr Paul); and Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam (Drs Miedema and Schellekens).

Footnotes
Accepted for publication Sept 1, 1987.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?